ÂÜÀòÂÒÂ×

Mike Sonnenberg is an experienced quality control executive with extensive expertise in biotechnology and pharmaceuticals. Currently serving as Executive Director of Quality Control at Autolus Therapeutics since October 2024, previous roles include Vice President of Quality Control at Fate Therapeutics Inc and Senior Director at Gilead Sciences and Kite Pharma. With a foundational career at Amgen, spanning from 1999 to 2015, Mike Sonnenberg held various leadership roles, culminating as Director, where responsibilities included managing analytical method transfers and quality metrics. Mike Sonnenberg earned a Master of Science degree in Microbiology from Colorado State University.